Regulation of DAPK1 by Natural Products: An Important Target in Treatment of Stroke

被引:5
|
作者
Noori, Tayebeh [1 ]
Shirooie, Samira [1 ]
Sureda, Antoni [2 ,3 ,4 ]
Sobarzo-Sanchez, Eduardo [5 ]
Dehpour, Ahmad Reza [6 ,7 ]
Saldias, Marianela [5 ]
Akkol, Esra Kupeli [8 ]
机构
[1] Kermanshah Univ Med Sci, Hlth Inst, Pharmaceut Sci Res Ctr, Kermanshah, Iran
[2] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress NUCOX, Palma De Mallorca 07122, Balearic Island, Spain
[3] Univ Balearic Isl, Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca 07122, Balearic Island, Spain
[4] Inst Salud Carlos III ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid 28029, Spain
[5] Univ Cent Chile, Fac Ciencias Salud, Inst Invest & Postgrad, Santiago, Chile
[6] Univ Tehran Med Sci, Expt Med Res Ctr, Tehran, Iran
[7] Univ Tehran Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran
[8] Gazi Univ, Fac Pharm, Dept Pharmacognosy, TR-06330 Ankara, Turkey
关键词
The death-associated protein kinase 1 (DAPK1); Stroke Natural product; Neurological disorders; PROTEIN-KINASE; 1; CEREBRAL-ISCHEMIA REPERFUSION; TUMOR-SUPPRESSOR DAPK; ISCHEMIA/REPERFUSION INJURY; SIGNALING PATHWAY; CELL-DEATH; RAT MODEL; CANCER CHEMOPREVENTION; DNA METHYLTRANSFERASES; AUTOPHAGY ACTIVATION;
D O I
10.1007/s11064-022-03628-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stroke is a sudden neurological disorder that occurs due to impaired blood flow to an area of the brain. Stroke can be caused by the blockage or rupture of a blood vessel in the brain, called ischemic stroke and hemorrhagic stroke, respectively. Stroke is more common in men than women. Atrial fibrillation, hypertension, kidney disease, high cholesterol and lipids, genetic predisposition, inactivity, poor nutrition, diabetes mellitus, family history and smoking are factors that increase the risk of stroke. Restoring blood flow by repositioning blocked arteries using thrombolytic agents or endovascular therapy are the most effective treatments for stroke. However, restoring circulation after thrombolysis can cause fatal edema or intracranial hemorrhage, and worsen brain damage in a process known as ischemia-reperfusion injury. Therefore, there is a pressing need to find and develop more effective treatments for stroke. In the past, the first choice of treatment was based on natural compounds. Natural compounds are able to reduce the symptoms and reduce various diseases including stroke that attract the attention of the pharmaceutical industry. Nowadays, as a result of the numerous studies carried out in the field of herbal medicine, many useful and valuable effects of plants have been identified. The death-associated protein kinase (DAPK) family is one of the vital families of serine/threonine kinases involved in the regulation of some biological functions in human cells. DAPK1 is the most studied kinase within the DAPKs family as it is involved in neuronal and recovery processes. Dysregulation of DAPK1 in the brain is involved in the developing neurological diseases such as stroke. Natural products can function in a variety of ways, including reducing cerebral edema, reducing brain endothelial cell death, and inhibiting TNF alpha and interleukin-1 beta (IL-1 beta) through regulating the DAPK1 signal against stroke. Due to the role of DAPK1 in neurological disorders, the aim of this article was to investigate the role of DAPK1 in stroke and its modulation by natural compounds. [GRAPHICS] .
引用
收藏
页码:2142 / 2157
页数:16
相关论文
共 50 条
  • [31] miR-124 Alleviates Ischemic Stroke-Induced Neuronal Death by Targeting DAPK1 in Mice (vol 15, 649982, 2021)
    Shi, Yan
    Tian, Tian
    Cai, Er-Li
    Yang, Can
    Yang, Xin
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [32] dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53
    Martoriati, A
    Doumont, G
    Alcalay, M
    Bellefroid, E
    Pelicci, PG
    Marine, JC
    ONCOGENE, 2005, 24 (08) : 1461 - 1466
  • [33] Autophagy: A potential target for natural products in the treatment of ulcerative colitis
    Zhang, Wei
    Zou, Menglong
    Fu, Jia
    Xu, Yin
    Zhu, Ying
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 176
  • [34] New natural products able to act on the stabilization of microtubules, an important target against cancer
    de Souza, MVN
    QUIMICA NOVA, 2004, 27 (02): : 308 - 312
  • [35] Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells
    Luo, Xiang-jian
    Li, Li-li
    Deng, Qi-pan
    Yu, Xin-fang
    Yang, Li-fang
    Luo, Fei-jun
    Xiao, Lan-bo
    Chen, Xiao-yan
    Ye, Mao
    Liu, Ji-kai
    Cao, Ya
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (02) : 316 - 325
  • [36] Grifolin,a potent antitumor natural product,upregulates death-associated protein kinase 1(DAPK1)via p53 in nasopharyngeal carcinoma cells
    LUO Xiang-jian1
    2Department of Phytochemistry
    中国病理生理杂志, 2010, 26 (10) : 2006 - 2006
  • [37] Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated dapk1 in human cancers and cancer cells
    Gade, Padmaja
    Singh, Ashish K.
    Roy, Sanjit K.
    Reddy, Sekhar P.
    Kalvakolanu, Dhananjaya V.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (07) : 1566 - 1574
  • [38] IDO1: An important immunotherapy target in cancer treatment
    Li, Fangxuan
    Zhang, Rupeng
    Li, Shixia
    Liu, Juntian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 47 : 70 - 77
  • [39] DAPK1 may be a potential biomarker for arterial aneurysm in clinical treatment and activated inflammation levels in arterial aneurysm through NLRP3 inflammasome by Beclin1
    Wu, Senyan
    Lu, Wei
    Cheng, Guobing
    Wu, Jiawen
    Liao, Sheng
    Hu, Qiang
    Li, Xiaoyang
    Jiang, Buping
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2021, 40 (12_SUPPL) : S563 - S572
  • [40] Natural products, an important resource for discovery of multitarget drugs and functional food for regulation of hepatic glucose metabolism
    Li, Jian
    Yu, Haiyang
    Wang, Sijian
    Wang, Wei
    Chen, Qian
    Ma, Yanmin
    Zhang, Yi
    Wang, Tao
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 121 - 135